Plasma viremia in macaques infected with simian immunodeficiency virus: Plasma viral load early in infection predicts survival

Journal of Virology

Volumn 71, Issue 1, 1997, Pages 284-290

  Watson, Andrew ^a   Ranchalis, Jane ^a   Travis, Bruce ^a   McClure, Janela ^a   Sutton, William ^a   Johnson, Philip R ^b   Hu, Shiu Lok ^a   Haigwood, Nancy L ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; LENTIVIRINAE; MACACA; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; SURVIVAL; VIREMIA; VIRUS TITRATION;

EID: 0031060156     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.1.284-290.1997     Document Type: Article

References (32)

1. Aoki-Sei, S., R. Yarchoan, S. Kageyama, D. T. Hoekzema, J. M. Pluda, K. M. Wyvill, S. Broder, and H. Mitsuya. 1992. Plasma HIV-1 viremia in HIV-1 infected individuals assessed by polymerase chain reaction. AIDS Res. Hum. Retroviruses 8:1263-1270.
2. Bagnarelli, P., S. Menzo, A. Valenza, A. Manzin, M. Giacca, F. Ancarani, G. Scalise, P. E. Varaldo, and M. Clementi. 1992. Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS. J. Virol. 66:7328-7335.
3. Cao, Y., D. D. Ho, J. Todd, R. Kokka, M. Urdea, J. D. Lifson, M. Piatak, Jr., S. Chen, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma. AIDS Res. Hum. Retroviruses 11:353-361.
4. Cao, Y., L. Qin, L. Zhang, J. Safrit, and D. D. Ho. 1995. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. New Engl. J. Med. 332:201-208.
5. Cullen, B. R. 1994. The role of nef in the replication cycle of the human and simian immunodeficiency viruses. Virology 205:1-6.
6. Dailey, P. J., J. A. Kolberg, M. Zamroud, M. G. Lewis, and M. S. Urdea. 1995. Quantitation of SIV RNA in plasma during acute infection of macaques using a branched chain (bDNA) signal amplification assay, abstr. D4-217. In Journal of Cellular Biology 1995. 24th Annual Keystone Symposia on Molecular and Cellular Biology.
7. Grant, R. M., B. Corliss, S. Staprans, H. McClure, and M. Feinberg. 1995. High level viremia with high diversity underlies nonpathogenic SIV infection of sooty mangabeys, abstr. D4-224. In Journal of Cellular Biology 1995. 24th Annual Keystone Symposia on Molecular and Cellular Biology.
8. Haigwood, N. L., W. F. Sutton, L. Misher, A. Watson, J. McClure, S.-L. Hu, G. Voss, N. L. Letvin, V. M. Hirsch, A. Lewis, and P. R. Johnson. 1996. Increased survival of SIV-infected macaques passively treated with antibody, p. 225-233. In F. Brown, E. Norrby, D. Burton, and J. Mekalanos (ed.), Molecular approaches to the control of infectious diseases. Cold Spring Harbor Laboratory Press, Plainview, N.Y.
9. Haigwood, N. L., A. J. Watson, W. F. Sutton, J. McClure, A. Lewis, J. Ranchalis, and B. Travis. 1996. Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile. Immunol. Lett. 51:107-114.
10. Hammer, S., C. Crumpacker, R. D'Aquila, B. Jackson, J. Lathey, D. Livnat, and P. Reichelderfer. 1993. Use of virologic assays for detection of human immunodeficiency virus in clinical trials: recommendations of the AIDS clinical trials group virology committee. J. Clin. Microbiol. 31:2557-2564.
11. Henrard, D. R., E. Daar, H. Farzadegan, S. J. Clark, J. Phillips, G. M. Shaw, and M. P. Busch. 1995. Virologic and immunologic characterization of symptomatic and asymptomatic primary HIV-1 infection. J. Acquired Immune. Defic. Syndr. 9:305-310.
12. Henrard, D. R., J. F. Phillips, L. R. Muenz, W. A. Blattner, D. Wiesner, M. E. Eyster, and J. J. Goedert. 1995. Natural history of HIV-1 cell-free viremia. JAMA 274:554-558.
13. Hirsch, V. M., T. R. Fuerst, G. Sutter, M. W. Carroll, L. C. Yang, S. Goldstein, M. Piatak, Jr., W. R. Elkins, W. G. Alvord, D. C. Montefiori, B. Moss, and J. D. Lifson. 1996. Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus ankara. J. Virol. 70:3741-3752.
14. Hollinger, F. B., J. W. Bremer, L. E. Myers, J. W. Gold, and L. McQuay. 1992. Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS clinical trials group. J. Clin. Microbiol. 30:1787-1794.
15. Hu, S.-L., N. L. Haigwood, and W. R. Morton. 1993. Non-human primate models for AIDS research, p. 293-327. In W. J. W. Morrow and N. L. Haigwood (ed.), HIV molecular organization, pathogenicity and treatment. Elsevier Science Publishers B.V., Amsterdam, The Netherlands.
16. Johnson, P. R., and V. M. Hirsch. 1992. SIV infection of macaques as a model for AIDS pathogenesis. Int. Rev. Immunol. 8:55-63.
17. Jurriaans, S., B. van Gemen, G. J. Weverling, D. van Strup, P. Nara, R. Coutinho, M. Koot, H. Schuitemaker, and J. Goudsmit. 1994. The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course. Virology 204:223-233.
18. Katzenstein, T. L., C. Pedersen, C. Nielsen, J. D. Lundgren, P. H. Jakobsen, and J. Gerstoft. 1996. Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome. AIDS 10:167-173.
19. Kestler, H. W., III, D. J. Ringler, K. Mori, D. L. Panicali, P. K. Sehgal, M. D. Daniel, and R. C. Desrosiers. 1991. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65:651-662.
20. Lin, H. J., L. E. Myers, B. Yen-Lieberman, F. B. Hollinger, D. Henrard, C. J. Hooper, R. Kokka, S. Kwok, S. Rasheed, M. Yahey, M. A. Winters, L. J. McQuary, P. L. Nara, P. Reichelderfer, R. W. Coombs, and J. B. Jackson. 1994. Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA. J. Infect. Dis. 170:553-562.
21. Mellors, J. W., L. A. Kingsley, C. R. Rinaldo, Jr., J. A. Todd, B. S. Hoo, R. P. Kokka, and P. Gupta. 1995. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Intern. Med. 122:573-579.
22. Mellors, J. W., C. R. Rinaldo, Jr., P. Gupta, R. M. White, J. A. Todd, and L. A. Kingsley. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167-1170.
23. Mulder, J., N. McKinney, C. Christopherson, J. Sninsky, L. Greenfield, and S. Kwok. 1994. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J. Clin. Microbiol. 32:292-300.
24. Pantaleo, G., S. Menzo, M. Vaccarezza, C. Graziosi, O. J. Cohen, J. F. Demarest, D. Montefiori, J. M. Orenstein, C. Fox, L. K. Schrager, J. B. Margolick, S. Buchbinder, J. V. Giorgi, and A. S. Fauci. 1995. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. New Engl J. Med. 332:209-216.
25. Piatak, M., Jr., M. S. Saag, L. C. Yang, S. J. Clark, J. C. Kappes, K.-C. Luk. B. H. Hahn, G. M. Shaw, and J. D. Lifson. 1993. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259:1749-1754.
26. Rinaldo, C., X.-L. Huang, Z. Fan, M. Ding, L. Beltz, A. Logar, D. Panicali, G. Mazzara, J. Liebmann, M. Cottrill, and P. Gupta. 1995. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J. Virol. 69:5838-5842.
27. Rump, J.-A., H.-H. Peter, J. Schneider, O. Haller, and A. Meyerhans. 1996. Long-term survivors with continuously high levels of HIV type 1. AIDS Res. Hum. Retroviruses 12:757-758.
28. Saag, M. S., M. Holodniy, D. R. Kuritzkes. W. A. O'Brien, R. Coombs, M. E. Poscher, D. M. Jacobsen, G. M. Shaw, D. D. Richman, and P. A. Volberding. 1996. HIV viral load markers in clinical practice. Nature Med. 2:625-629.
29. Saksela, K., C. E. Stevens, P. Rubinstein, P. E. Taylor, and D. Baltimore. 1995. HIV-1 messenger RNA in peripheral blood mononuclear cells as as an early marker of risk for progression to AIDS. Ann. Intern. Med. 123:641-648.
30. Todd, J., C. Pachl, R. White, T. Yeghiazarian, P. Johnson, B. Taylor, M. Holodniy, D. Kern, S. Hamren, D. Chernoff, and M. Urdea. 1995. Performance characteristics for the quantitation of plasma HIV-1 RNA using branched DNA signal amplification technology. J. Acquired Immune Defic. Syndr. 10(Suppl. 2):S35-S44.
31. Winters, M. A., L. B. Tan, D. A. Katzenstein, and T. C. Merigan. 1993. Biological variation and quality control of plasma human immunodeficiency virus type 1 RNA quantitation by reverse transcriptase polymerase chain reaction. J. Clin. Microbiol. 31:2960-2966.
32. Wyand, M. S. 1992. The use of SIV-infected rhesus monkeys for the preclinical evaluation of AIDS drugs and vaccines. AIDS Res. Hum. Retroviruses 8:349.